-
Interstitial pneumonitis associated with EGFR/ALK tyrosine kinase inhibitors used in non-small cell lung cancer: an observational, retrospective, pharmacovigilance study
Author: Ma, Zhuo; Pei, Jie; Zhang, Yi; Li, Hao; Sun, Dan; Zhang, Yuhui; An, Zhuoling
Journal: EXPERT OPINION ON DRUG SAFETY. 2023; Vol. 22, Issue 3, pp. 237-242. DOI: 10.1080/14740338.2022.2110235
-
Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study
Author: Wu, Junyan; Huang, Jianxiang; Zhu, Jianhong; He, Zhichao; Chen, Mengting; Gao, Siyuan; Liang, Dan; Yu, Xiaoxia; Lu, Chengyu
Journal: EXPERT OPINION ON DRUG SAFETY. 2023; Vol. 22, Issue 3, pp. 231-235. DOI: 10.1080/14740338.2022.2110234
-
Lack of association between febrile seizures and vaccines containing diphtheria, tetanus, and acellular pertussis in Chinese children
Author: Xu, Lu; Li, Ning; Zhang, Liang; Ma, Rui; Fang, Ting; Liu, Zhike; Zhan, Siyan
Journal: EXPERT OPINION ON DRUG SAFETY. 2023; Vol. 22, Issue 3, pp. 253-258. DOI: 10.1080/14740338.2022.2116000
-
Comparative Efficacy and safety of new targeted therapies and immunotherapies for metastatic triple negative breast cancer: a network meta-analysis
Author: Leung, John Hang; Tai, Yun-Sheng; Wang, Shyh-Yau; Tsung-Chin, Ho; Yip Fion, Hei-Tung; Chan, Agnes L. F.; Yu-Chen, Hsu
Journal: EXPERT OPINION ON DRUG SAFETY. 2023; Vol. 22, Issue 3, pp. 243-252. DOI: 10.1080/14740338.2022.2116001
-
Angiotensin receptor-neprilysin inhibitor and sodium-dependent glucose cotransporter-2 inhibitor-associated renal injury: a pharmacovigilance study
Author: Chen, Chen; Wu, Bin; Zhang, Chenyu; Xu, Ting
Journal: EXPERT OPINION ON DRUG SAFETY. 2023; Vol. 22, Issue 3, pp. 259-266. DOI: 10.1080/14740338.2022.2120609
-
Pharmacovigilance analysis of cardiac risks associated with Bruton tyrosine kinase inhibitors
Author: Zhai, Yinghong; Hu, Fangyuan; Shi, Wentao; Ye, Xiaofei; Xu, Jingfang; Guo, Xiaojing; Cao, Yang; He, Jia; Xu, Feng
Journal: EXPERT OPINION ON DRUG SAFETY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14740338.2023.2204226
-
PD-1/PD-L1 inhibitors-associated cardiac adverse events: a retrospective and real-world study based on the FDA Adverse Event Reporting System (FAERS)
Author: Wang, Qiaoyun; Xiao, Fengjiao; Zeng, Yanbin; Zhu, Qiaoling; Zhang, Haixia
Journal: EXPERT OPINION ON DRUG SAFETY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14740338.2023.2203483
-
Data mining for signal detection of adverse events for taxanes based on the food and drug administration adverse drug events reporting system database
Author: Wang, Lin-Yu; Liao, Liu-Feng; Lei, Cai-Lu; Wu, Qiong; Guo, You-Jia; Li, Yan
Journal: EXPERT OPINION ON DRUG SAFETY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14740338.2023.2203487
